Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
Plos One
|
October 22, 2021
The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies
Reed F Beall, Javad Moradpour, Aidan Hollis
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal
|
November 27, 2014
Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines
Reed F Beall, Jason W Nickerson, Amir Attaran
Journal of Managed Care & Specialty Pharmacy
|
January 31, 2019
New Drug Formulations and Their Respective Generic Entry Dates
Reed F Beall, Aaron S Kesselheim, Ameet Sarpatwari
Journal of Pharmaceutical Policy and Practice
|
May 4, 2016
Upstream solutions for price-gouging on critical generic medicines
Adam R Houston, Reed F Beall, Amir Attaran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 29, 2021
Premarket Development Times for Innovative Vaccines--To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
Reed F Beall, Aaron S Kesselheim, Aidan Hollis
Nature Biotechnology
|
June 20, 2019
Pre-market development times for biologic versus small-molecule drugs
Reed F Beall, Thomas J Hwang, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 4, 2018
A Method for Approximating Future Entry of Generic Drugs
Reed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Health Policy (Amsterdam, Netherlands)
|
October 12, 2019
How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?
Reed F Beall, Lorian Hardcastle, Fiona Clement, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
April 18, 2019
Approximating Future Generic Entry for New Drugs
Reed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Applied Health Economics and Health Policy
|
August 25, 2018
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents
Jonathan J Darrow, Reed F Beall, Aaron S Kesselheim
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
Plos One
|
October 22, 2021
The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies
Reed F Beall, Javad Moradpour, Aidan Hollis
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal
|
November 27, 2014
Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines
Reed F Beall, Jason W Nickerson, Amir Attaran
Journal of Managed Care & Specialty Pharmacy
|
January 31, 2019
New Drug Formulations and Their Respective Generic Entry Dates
Reed F Beall, Aaron S Kesselheim, Ameet Sarpatwari
Journal of Pharmaceutical Policy and Practice
|
May 4, 2016
Upstream solutions for price-gouging on critical generic medicines
Adam R Houston, Reed F Beall, Amir Attaran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 29, 2021
Premarket Development Times for Innovative Vaccines--To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
Reed F Beall, Aaron S Kesselheim, Aidan Hollis
Nature Biotechnology
|
June 20, 2019
Pre-market development times for biologic versus small-molecule drugs
Reed F Beall, Thomas J Hwang, Aaron S Kesselheim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 4, 2018
A Method for Approximating Future Entry of Generic Drugs
Reed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Health Policy (Amsterdam, Netherlands)
|
October 12, 2019
How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?
Reed F Beall, Lorian Hardcastle, Fiona Clement, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
April 18, 2019
Approximating Future Generic Entry for New Drugs
Reed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Applied Health Economics and Health Policy
|
August 25, 2018
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents
Jonathan J Darrow, Reed F Beall, Aaron S Kesselheim
Page
of 7